Denise Braendgaard: OneSCD Brings Sickle Cell Disease to the Global Stage
Denise Braendgaard, General Manager at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, shared a post on LinkedIn, adding:
“The launch of OneSCD at the United Nations General Assembly UNGA81 marks an important milestone for the sickle cell disease community.
For me, OneSCD brings the full circle into focus: local realities, continental collaboration, global alignment and country-led action.
Just three weeks ago, I was in Dar es Salaam, Tanzania, with our partners from Tanzania and other key African countries carrying a high burden of sickle cell disease, celebrating the launch of the partnership between Africa CDC and the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation (NNHF) for the implementation of the Continental Plan for Sickle Cell Disease and Other Inherited Blood Disorders.
Now, OneSCD brings this country and continental momentum to the global stage.
Global alignment matters, and lasting impact happens at country level. Countries most affected must have a meaningful voice in shaping priorities and solutions. At NNHF, we will continue working alongside governments, partners and communities to translate shared priorities into locally led, sustainable action.
One message is clear: where a person lives should not determine whether they can access diagnosis, quality care and treatment.
Thank you to the Government of the Federal Republic of Nigeria, St. Jude Children’s Research Hospital, World Health Organization, UNICEF, Africa CDC, World Coalition on Sickle Cell Disease (WCSCD) and all partners for your leadership in bringing this community together and advancing global alignment on sickle cell disease!”
Other posts featuring Denise Braendgaard on Hemostasis Today.
-
Sep 26, 2026, 09:49Manuel Monreal: Acute VTE in Patients With Severe Renal Insufficiency
-
Sep 26, 2026, 09:38New TIF Guidelines for Emergency Care in Thalassaemia and SCD
-
Sep 26, 2026, 09:28Annette Bowyer: Rethinking Product Specific Calibrators in Haemophilia
-
Sep 26, 2026, 09:21Nisanth Menon: When Emergency Medicine Meets Transfusion Medicine
-
Sep 26, 2026, 07:50Giuseppe Andò: P2Y12 Inhibition in Diabetes – A Personalized Approach
-
Sep 26, 2026, 07:36Tiffany Hall: Honored to Be Recognized for Advancing Blood Health
-
Sep 26, 2026, 07:23Jignesh Patel: Call for Papers on Safer IV Unfractionated Heparin Use
-
Sep 26, 2026, 07:03Robert Tadevosyan: From Scientific Day to the Stago Factory
-
Sep 26, 2026, 07:01David McIntosh: Plasma Derived Medicines and the Global Access Gap